The conduct of many trials for the successful production of large quantities of pure proteins for structural biology and biotechnology applications, particularly of active, authentically processed enzymes, large eukaryotic multi-subunit complexes and membrane proteins, has spurred the development of recombinant expression systems. Beyond the well-established Escherichia coli, mammalian cell culture and baculovirusinfected insect cell expression systems, a plethora of alternative expression systems has been discovered, engineered, matured and deployed, resulting in crystal, nuclear magnetic resonance, and electron microscopy structures. In this review, we visit alternative expression hosts for structural biology ranging from bacteria and archaea to filamentous and unicellular yeasts and protozoa, with particular emphasis on their applicability to the structural determination of high-value, challenging proteins and complexes.
Introduction
Recombinant protein production stands as an enabling technology in the life sciences and plays a crucial role in biotechnology and structural biology. At present, Escherichia coli ranks as the most prevalent microbial factory in structural biology as it has been used to produce more than 66 724 (88.6%) of all distinct protein chains in the Protein Data Bank (PDB) with a non-empty descriptor for 'Expression Host' (Figure 1a ). Insect cells (including baculovirus-infected insect cells and Drosophila Schneider cells) rank second, accounting for 3499 distinct protein chains (4.65%), while mammalian cells occupy the third position with 1911 distinct protein chains (2.54%) (Figure 1a ). The remaining 3102 protein chains have been expressed in 67 different expression hosts spanning the three domains of life with half of these entries recording a yeast expression system for their production (1658 protein chains or 2.20%) (Figure 1a ). These dominant expression platforms share widespread use and a wealth of available resources (material and knowledge) and their performance has been demonstrated for many heterologous proteins and multi-subunit complexes (Figures 2 and 3) . Hence, the cost associated with their adoption for a new protein production project is generally lower than trying less tested hosts. Nevertheless, research on unconventional expression hosts represents a valuable addition by shedding light on organisms with orthogonal genomic, metabolic, and recombinant expression properties ( Table 1 ) that can outperform more established hosts for specific protein families -as specialty systems. This review aims to summarize stateof-the-art alternative expression hosts including various bacteria, archaea, filamentous fungi, yeasts, and protozoa, all of which have been successfully used in structural biology within the last decade (Table 1 and Figures 1 and  3) ; inevitably, several hosts will be left out from this selection: cell-free systems, algae and plants, and bacteria taxonomically redundant with those already included (Figure 1b and c) . Except when noted otherwise, none of these expression hosts poses a threat to our health. Furthermore, we will touch briefly on what the future may hold for these unconventional hosts.
Alternative bacterial expression hosts

Pseudomonas
Pseudomonas spp. (typically P. putida, P. aeruginosa, P. fluorescens and P. alcaligenes) include Gram-negative rods with strict aerobic metabolism [1 ] that grow at 30-428C on inexpensive wastage products like corn molasses and can be transformed with plasmid DNA by chemical methods and by plasmid conjugation from E. coli [2] . P. aeruginosa is a moderate potential hazard for staff and the environment thereby requiring biosafety level 2 (S2) containment. Its relatively high G + C content (60.5-66.6% among sequenced species) makes Pseudomonas an ideal host for the expression of certain restriction endonucleases [3 ] (Figure 2a ) and naturally G + C rich gene products, for example, HsaD from M. tuberculosis [4] . Recombinant expression in Pseudomonas may be driven by temperature (428C) using the temperature-sensitive P L promoter as well as other promoters such as the IPTGinducible tac promoter, the alkane hydroxylase gene promoter (alkBp) [5, 6] , the regulatory control region for naphthalene and phenanthrene degradation from Comamonas testosteroni (inducible by sodium salicylate) [7] , and the Pm/xylS expression system (Vectron Biosolutions AS) inducible by toluinic acid and other benzoic acids. Proteins expressed with this host include, among others, enzymes, receptors, fimbrial proteins, and heme-containing proteins. So far, 58 PDB entries report Pseudomonas as expression host of both homologous and heterologous proteins from other pathogenic bacteria and bacteriophages. Interestingly, non-pathogenic Pseudomonas species have been used to express and crystallize own membrane proteins and virulence factors.
Bacillus
B. subtilis and B. megaterium are Gram-positive soil bacteria increasingly used as hosts for intra-cellular and especially extracellular protein production that have grown over the past decade into attractive alternatives to E. coli because their genomes are fully sequenced [8, 9] , due to their GRAS (generally regarded as safe) status and the development of an extensive tool-kit of gene expression plasmids and production strains. Both stable episomal and integrative plasmids are available that can be efficiently delivered by protoplast transformation or transconjugation. Recombinant expression is typically driven from the xylose-inducible P xylA [10] or from T7 RNA polymerase [11] promoters. Even though B. subtilis is currently more widely used in structural biology, the strong push to develop B. megaterium as the standard Gram-positive microbial factory for protein production, which includes a commercial version (MoBiTec) and ongoing efforts to characterize it at a systems biology level [12 ] , may change these numbers in the future. The 198 PDB entries reporting Bacillus as expression host include diverse glycoside hydrolases, lipases, proteases, as well as insecticidal peptides, virulence factors, for example, anthrax lethal factor and Clostridium difficile toxin A [13] (Figure 2b ) and phage DNA polymerases.
Streptomyces
Several Streptomyces strains have been used for the production of proteins for 67 PDB entries, mostly S. lividans TK24 because of its exceptionally low level of extracellular proteases. These mycelial Actinobacteria are versatile Number of expression hosts used for recombinant protein production for structural biology, expressed either as percentage of unique protein chains in the PDB or as a count of unique chains and PDBs per host. Only PDB entries with a non-empty 'Expression Host' field are considered, amounting to 67 690 PDB entries containing 66 722 unique protein chains in total. Absolute counts and frequencies of expression host usage are depicted as pie charts. When several expression hosts are grouped together as Other, the total number of implied hosts is shown in parentheses. (a) E. coli, baculovirus-infected insect cells, and mammalian cells represent the dominant expression hosts in the PDB, together accounting for nearly 96% of all unique chains in protein structures. (b) Summarized statistics for alternative recombinant expression hosts, including yeasts and 'other' hosts in (a); hosts are grouped according to their taxonomic classification and, for yeasts, refined on the basis of their metabolic capacity to assimilate methanol (methylotrophic and non-methylotrophic yeasts). The area of each pie chart is in proportion to the contribution that each host set makes to the total number of protein chains expressed with alternative hosts; this frequency is shown underneath the pie charts. (c) As in (b), for alternative hosts not described in the text (plant/algae and cell-free systems).
Technologies to keep an eye on: alternative hosts for protein production in structural biology Ferná ndez and Vega 367 k Learning curve tries to capture the approximate time it would take a scientist with previous exposure only to E. coli expression to become proficient (i.e. productive mostly independently) in the other expression system; no expert guidance is assumed since intensive next-door expert training or translational access programs to dedicated expert facilities would certainly accelerate learning these technologies. l Time: time in weeks for an experienced user from start of project to the first large-scale expression culture, hence spanning cloning, transformation and selection, small-scale expression trials, and large-scale expression culture. m Economic cost is a complex variable that depends on any particular target protein, dedicated person-months and length of the overall process (from clone to purified protein), gene synthesis (or not), target yield, fermentation scale, and the combined costs of media, antibiotics, inducers, and other reagents. Hence, the values shown are merely a rough guide that might oscillate (upwards and downwards). Low, comparable to the cost involved in the soluble expression of a single-domain protein in E. coli (estimated at $1000 from cloning to expressed protein); moderate, 2-5-fold higher overall cost; high, >5-fold higher cost. n Recommended use: highlighted/recommended applications suggesting potential areas with the greatest promise for further development for each host. Gallery of crystal structures where proteins were overexpressed using an unconventional platform. (a) Restriction endonuclease PacI complexed with its DNA recognition sequence expressed homologously in Pseudomonas alcaligenes (3MK7) [3 ] . (b) Glucosyltransferase domain from Clostridium difficile toxin A bound to UDP-glucose expressed in Bacillus megaterium (3SRZ) [13] . (c) O-carbamoyltransferase TobZ from Streptoalloteichus tenebrarius expressed in Streptomyces lividans (3VEN) [14] . (d) KasA protein (3-oxoacyl-[acyl-carrier-protein] synthase) from Mycobacterium tuberculosis expressed in Mycobacterium smegmatis (2WGD) [17 ] . (e) T90A/D115A mutant bacteriorhodopsin expressed homologously in Halobacterium salinarum (3COD) [22] . (f) D73 C-terminally truncated plasma membrane proton pump from Arabidopsis thaliana expressed in hosts for the production of secondary metabolites accounting for half of all commercialized antibiotics and are especially indicated for antibiotic peptides and enzymes involved in antibiotic biosynthesis and drug modification, for example, the O-carbamoyl transferase TobZ [14] (Figure 2c ). Several strong promoters are available controlled by phosphate starvation, inducible by erythromycin, and the hyper-inducible nitrilase promoters [15] , as well as hybrid promoters employed to drive expression from a T7 promoter to very high levels [16] . Hence, Streptomyces strains appear particularly well suited for the recombinant production of antibiotic and drug-modifying enzymes in addition to peptides and small-molecule antibiotics and drugs.
Mycobacterium
Two fully sequenced, non-pathogenic species for human, M. smegmatis and M. vaccae, have been successfully exploited for the production of M. tuberculosis proteins in work spearheaded by the M. tuberculosis structural genomics consortium that has resulted in 5 and 1 deposited PDB entries, respectively. Even if those entries represent only a small fraction of the >1000 structures concerning M. tuberculosis proteins, they include Mycobacterial antigens, Technologies to keep an eye on: alternative hosts for protein production in structural biology Ferná ndez and Vega 369 Saccharomyces cerevisiae (3B8C) [33 ] . (g) Unliganded human CD21 (complement receptor 2, CR2) SCR domains 1-2 expressed in Pichia pastoris (1LY2) [39 ] . (h) Glucohydrolase 61 (GH61) isozyme A (post-translationally modified by methylation and two disulfide bridges) from Thermoascus aurantiacus expressed in Aspergillus oryzae (2YET) [50 ] . (i) Human Cu/Zn superoxide dismutase (SOD1) expressed in Leishmania tarentolae (3KH4) [53 iron-superoxide dismutase, and cell-wall and specific lipid biosynthetic enzymes [17 ] (Figure 2d ) that may have required elaborate strategies for their expression in E. coli. Vectors for recombinant expression in M. smegmatis usually drive expression from the strong acetamidase promoter, which is induced by acetamide at mid-log phase and peaks at 24-36 hours [17 ,18] . M. smegmatis and M. vaccae represent invaluable additions to the protein expression toolbox of researchers dealing with enzymes involved in M. tuberculosis specific pathways.
Archaeal expression hosts
Bacteriorhodopsins are model systems for light-harvesting membrane proteins and can be obtained in large amounts from the natural source owing to their strong constitutive expression. However, investigation of mutant bacteriorhodopsins cannot simply rely on the natural source or time-consuming and labor-intensive genome mutagenesis, therefore providing an incentive to developing recombinant systems to express bacteriorhodopsins. One such system uses the extreme halophilic Euryarcheaota Halobacterium salinarum (syn. halobium) [19] [20] [21] , which has been harnessed in 46 PDB entries, including several mutant structures [22] (Figure 2e) ; another extreme halophilic archaeon, Natromonas pharaonis, has been used at least once (PDB 1JGJ). Shuttle E. coli-Halobacterium vectors have been constructed that contain the pHH9 H. salinarum replication origin, E. coli tetracycline resistance gene (Tet r ) and the H. volcanii novobiocin resistance gene (Nov r ) [23] . In addition, human G-protein coupled beta2-adrenergic receptor has also been successfully expressed in H. salinarum [24 ] , thus providing proof-of-concept of the potential usefulness of these archaeal hosts for the production of mammalian membrane proteins in general and GPCRs in particular.
Yeasts expression systems
These single-celled fungi have been extensively researched as hosts for heterologous protein production, including non-methylotrophic genera as Saccharomyces, Schizosaccharomyces, Kluyveromyces [25] , and Yarrowia [26] , and methylotrophic genera as Pichia pastoris (syn. Komagataella phaffii) [27, 28] and Ogataea (Hansenula) polymorpha (syn. P. angusta) [29, 30, 31 ]. Attractive features include well-known genetics and metabolism, easy to perform gene knockout and gene replacement, availability of strong promoters (constitutive as well as tightly controlled and inducible), and fast growth to very high cell densities on inexpensive media (in microtiter plate, shake flask and bioreactors). Being lower eukaryotes, yeasts can perform many post-translational modifications as higher eukaryotes and in particular possess a secretory pathway capable of correct protein processing and highmannose glycosylation. With serious efforts well underway to engineer humanized glycosylation in several yeasts platforms, available tools for whole genome analysis and metabolic flux analysis in yeast render them promising tools for present and future biotechnology.
Non-methylotrophic yeasts
763 distinct protein chains in 639 PDB entries list a nonmethylotrophic yeast as the recombinant host for expression. Of those, Saccharomyces cerevisiae is the most frequently used (741) followed by Yarrowia (11), Kluyveromyces lactis (8) and Schizosaccharomyces pombe (3). Nearly 50% of them are human soluble proteins and protein complexes [32 ] , but there are also membrane proteins [33 ] (Figure 2f ) and even viral capsids completely reconstituted in yeast.
Methylotrophic yeasts
These yeasts can feed on methanol as sole carbon and energy source and represent the yeast-based expression host with the highest adoption rate; especially because of the high cell densities they reach in mineral minimum medium and the strength of the alcohol oxidase 1 (AOX1) and methanol and nitrogen-regulated FLD [34] promoters or the constitutive GAP promoter [35] . Heterologous production of fungal, plant, mammalian and human proteins is well-documented, especially by secretion to the extracellular medium. Highlight examples of this strategy are the full-length versions of innate immunity proteins and protein complexes, for example, complement control proteins and complement receptors, including the human decay-accelerating factor (DAF, CD55) [36] , and human complement receptors 1 (CR1) [37, 38] and 2 (CR2, CD21) [39 ] (Figure 2g ). To date, P. pastoris has been employed in about 880 PDB entries since first reported in the 1994 NMR structure of tick anticoagulant peptide [40] .
Filamentous fungi
Aspergillus
In contrast to yeasts and the other microbial factories described here, Aspergillus is a multicellular organism, a filamentous fungus. Several Aspergillus species, chiefly A. niger and A. oryzae, are workhorses in many biotechnology applications [41, 42 ] and have also been used in structural biology. Their amenable genetics and strain optimization features, an unmatched capacity for secreting homologous and heterologous enzymes, as well as detailed knowledge of its industrial-scale fermentation, make Aspergillus an attractive expression host. Random mutagenesis screenings aimed at abolishing the proteolytic secretoma have also succeeded in isolating mutants with 98% less proteolytic activity than the wild type, apparently by the gene disruption of a fungal-specific master regulator of protease gene expression [43] . Although harder to transform than yeasts, methods for the efficient transformation of Aspergillus have been developed that include Agrobacterium tumefaciensmediated DNA transfer [44] and transformation of protoplasts after enzymatic cell wall degradation [45] . Both constitutive and inducible promoters are available for A. niger expression of foreign proteins, with inducible promoters being preferred because of the beneficial effect on protein yield of decoupling biomass production and protein expression (e.g. in the production of toxic proteins). Two inducible promoters are commonly used, the A. niger glucoamylase gene promoter PglaA repressed by xylose and highly induced when maltose or starch is used as single carbon source [46] and the A. nidulans alcohol dehydrogenase gene promoter PalcA, induced by ethanol and derivatives [47] . Recently, promising human estrogen inducible promoters ensuring both tight regulation and a linear inducer response have been developed [48] . Glycosylation in Aspergillus is of the high mannose type and both N-linked glycosylation and O-linked glycosylation are efficiently catalyzed. The Aspergillus toolbox was until recently lacking in expression vectors encoding fusion tags for purification [49] . To date, 130 NMR and X-ray crystal structures of fungal proteins expressed in A. niger and A. oryzae have been reported, for example, [50 ] (Figure 2h ), demonstrating the feasibility of using filamentous fungi for protein production for structural biology applications, which require very homogeneous, pure and abundant protein. In fact, some of the above issues have been addressed and solved, the greatest success having been reached using synthetic gene sequences which were codon optimized for A. niger [51] .
Protozoa
Leishmania tarentolae
Several characteristics of L. tarentolae make it a convenient microorganism for the production of authentically processed eukaryotic proteins: this trypanosomatid protozoan infects lizards and is non-human pathogenic; therefore it is innocuous and only requires biosafety level 1 laboratories; and it is a robust organism that grows optimally at 268C and can be kept under sterile conditions outside the hood using a flame. Constitutive or inducible vectors for intracellular or secretion expression are commercially available with optimized splicing signals for expression of heterologous proteins [52] , which can be either stably integrated into the genome (typically into the strongly transcribed 18S rRNA locus) or maintained episomally. L. tarentolae cells, transformed by electroporation, can grow in adherent culture or be cultivated to higher densities in shaking cultures (5 Â 10 8 cells/ml) in inexpensive, bacteriological media without serum. Examples of expressed proteins include human erythropoietin and interferon-gamma. To date, two PDB entries report having used L. tarantolae as expression host in two different crystal forms of human Cu/Zn superoxide dismutase [53 ] (Figure 2i ).
Dictyostelium discoideum
The social amoeba D. discoideum is recommended as a non-mammalian model organism for functional analysis of sequenced genes by the National Institutes of Health (Bethesda, MD, USA) since it provides an intermediate level of complexity between yeasts and plants and animals [54] . More than 30 genes orthologous to human disease genes have been found in D. discoideum 34 Mb genome, which shows a higher degree of gene conservation with higher eukaryotes than with fungi [55] . With an A + T content of >75%, the expression of certain genes has been enhanced by gene optimization (adjusting for a similar codon preference) and using authentic signal sequences [56, 57] . Foreign DNA is efficiently delivered to D. discoideum by electroporation and transformants can be cultured xenically on a bacterial food source or axenically on simple salt medium, with a doubling time of 4-12 hours that exceeds the growth rate of mammalian cells. D. discoideum performs mammalian-style N-linked and Olinked glycosylation but cannot accomplish complex terminal glycosylation since it lacks the ability to add galactose, N-acetyl galactosamine, or sialic acids [58, 59] . In fact, several therapeutic glycoproteins have been successfully expressed in D. discoideum including rotavirus VP7, muscarinic receptor m2 and m3, antithrombin III, gonadotropins, or erythropoietin. The most remarkable applications of D. discoideum in structural biology concern the production of wild-type, chimeric, and mutant motor proteins, for example, the actin-tropomyosin-myosin rigor complexes [60] (Figure 2j ) and dynein [61] .
Conclusion
Success in recombinant protein expression for structural biology involves making crucial choices about construct design, coexpression partners, culture parameters, and induction regime, among many others -including switching to unconventional expression hosts that may be particularly well-suited to the target gene for various reasons (Figure 3 ). These lesser known organisms, which can accomplish expression of heterologous proteins (as general purpose hosts or 'generalists') as well as revealing themselves most valuable when over-producing their own proteins or specific classes of macromolecules (as 'specialist' hosts) (Figure 3b ), include Gram-negative and Grampositive bacteria, extreme halophilic archaea, and eukaryotic fungi (yeast and filamentous fungi) and protozoa. As demonstrated in more than 3100 distinct PDB protein chains, these hosts can efficiently generate high yields of proteins endowed with correct fold, activity, and posttranslational modifications, and possess sufficient quality for structural and biophysical analysis. Growing access to those hosts via commercial or academic ready-to-use toolkits should facilitate their comparative screening and the solid experimental assessment of their relative merits for the production of different classes of proteins and protein complexes.
